DOW Expands Sustainable PG Solution Offerings in Asia Pacific
Werte in diesem Artikel
DOW Incorporation DOW announced that its Propylene Glycol (“PG”) manufacturing facility in Map Ta Phut, Rayong, Thailand has earned the International Sustainability and Carbon Certification (“ISCC”) PLUS. This achievement will enable DOW to expand its offering of circular or bio-circular solutions to customers in Asia Pacific.The two new sustainable PG products that will be available are Propylene Glycol CIR featuring Renuva and Propylene Glycol REN featuring Ecolibrium. These have been designed to suit a broad range of applications across industries, including personal care, pharmaceutical, food ingredients, flavorings and fragrances. The products will also help customers achieve their circular and sustainability goals.The certification has ensured DOW’s global leadership in sustainable production and a circular future. The ISCC certification, along with capacity expansion, has positioned the Map Ta Phut PG facility to serve customers in the best way possible, both locally and regionally. The DOW stock has lost 36.4% in the past year compared with 14.6% decline of the industry.Image Source: Zacks Investment ResearchMoving ahead, management stated that the company expects to gain from the completion of its near-term incremental growth projects and increased focus on operational discipline in 2025. It is optimistic about a further increase in demand in attractive end markets, such as packaging, energy and electronics. DOW expects the strong balance sheet and differentiated portfolio to allow it to deliver on capital allocation priorities. The company is taking actions to cut costs by $1 billion to drive margins. It expects to achieve the majority of the cost savings through a $500-$700 million reduction in direct costs and decreased labor costs, including through a workforce reduction of around 1,500 roles globally. DOW is also reducing 2025 capital spending plans by $300-$500 million. This move is in response to ongoing macroeconomic challenges and to support its long-term growth targets.DOW’s Zacks Rank and Key PicksDOW currently carries a Zacks Rank #5 (Strong Sell).Some better-ranked stocks in the Basic Materials space are Ingevity Corporation NGVT, Axalta Coating Systems AXTA and Carpenter Technology Corporation CRS. While NGVT and AXTA sport a Zacks Rank #1 (Strong Buy) each at present, CRS carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Ingevity’s current-year earnings is pegged at $4.45 per share. NGVT's earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, the average surprise being 202.9%.The Zacks Consensus Estimate for Axalta’s current-year earnings is pegged at $2.51 per share. AXTA's earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 16.28%.The Zacks Consensus Estimate for Carpenter Technology’s current fiscal-year earnings is pegged at $6.95 per share. CRS' earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average surprise being 15.7%. Its shares have soared 185.1% in the past year. 5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dow Inc. (DOW): Free Stock Analysis Report Carpenter Technology Corporation (CRS): Free Stock Analysis Report Axalta Coating Systems Ltd. (AXTA): Free Stock Analysis Report Ingevity Corporation (NGVT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Dow und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Dow
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Dow
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Procter & Gamble Co.
Analysen zu Procter & Gamble Co.
Datum | Rating | Analyst | |
---|---|---|---|
30.03.2022 | ProcterGamble Neutral | JP Morgan Chase & Co. | |
20.10.2020 | ProcterGamble Sector Perform | RBC Capital Markets | |
23.10.2019 | ProcterGamble buy | Goldman Sachs Group Inc. | |
30.07.2019 | ProcterGamble Sector Perform | RBC Capital Markets | |
24.04.2019 | ProcterGamble Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
23.10.2019 | ProcterGamble buy | Goldman Sachs Group Inc. | |
24.04.2019 | ProcterGamble Overweight | Barclays Capital | |
14.12.2017 | ProcterGamble Buy | Deutsche Bank AG | |
27.04.2017 | ProcterGamble Hold | Stifel, Nicolaus & Co., Inc. | |
15.02.2017 | ProcterGamble kaufen | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
30.03.2022 | ProcterGamble Neutral | JP Morgan Chase & Co. | |
20.10.2020 | ProcterGamble Sector Perform | RBC Capital Markets | |
30.07.2019 | ProcterGamble Sector Perform | RBC Capital Markets | |
24.04.2019 | ProcterGamble Neutral | Credit Suisse Group | |
23.04.2019 | ProcterGamble Neutral | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Procter & Gamble Co. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen